UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - alzheimers+disease
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Nisin-Based Formulations for Oral and Systemic Conditions (UCLA Case Nos. 2023-133 and 2022-306)
UCLA researchers in the Department of Dentistry have found a novel use for nisin alone, and in formulations, for use in the treatment of Alzheimer’s disease, and multiple inflammation states such as brain inflammation, joint inflammation, oral inflammation, systemic inflammation, inflammatory bowel diseases, and non-alcoholic fatty liver disease...
Published: 9/19/2024
|
Inventor(s):
Yvonne Kapila
Keywords(s):
Alzheimers disease
,
Antibacterial
,
gut inflammation
,
Inflammation
,
microbiome
,
nanoparticle delivery system
,
Nanoparticles
,
nisin
,
oral inflammation
,
periodontal disease
,
periodontal inflammation
,
periodontal regeneration
Category(s):
Therapeutics > CNS and Neurology
Small Molecule Humanin Mimetics and Enhancers That Normalize Neuronal p-AKT as Novel Therapeutics for Alzheimer's Disease (UCLA Case No. 2023-230)
UCLA researchers in the Department of Neurology have discovered novel small molecule humanin mimetics for the treatment of Alzheimer's disease and other chronic conditions with dysregulated p-Akt. BACKGROUND: Alzheimer’s disease (AD) is the most common form of dementia accounting for 60-70% of all cases. Nearly 7 million Americans are living...
Published: 7/22/2024
|
Inventor(s):
Varghese John
Keywords(s):
Alzheimers disease
,
Cardiovascular
,
Cardiovascular Disease
,
Dementia
,
diabetes
,
mimetics
,
pAKT signaling
,
small molecules
Category(s):
Therapeutics > CNS and Neurology
,
Therapeutics > Cardiovascular